The use of pedigree, sib-pair and association studies of common diseases for genetic mapping and epidemiology

Nature Genetics

Volumn 36, Issue 10, 2004, Pages 1045-1051

  Freimer, Nelson ^a,b,c   Sabatti, Chiara ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; CASPASE RECRUITMENT DOMAIN PROTEIN 15;

AFFECTED SIBING PAIR ANALYSIS; ALZHEIMER DISEASE; BIPOLAR DISORDER; BRAIN INJURY; CHROMOSOME 16; CROHN DISEASE; GENE IDENTIFICATION; GENE MAPPING; GENETIC ANALYSIS; GENETIC EPIDEMIOLOGY; GENETIC VARIABILITY; HUMAN; LINKAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PEDIGREE ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SIBLING; SINGLE NUCLEOTIDE POLYMORPHISM; CHROMOSOME MAP; EPIDEMIOLOGY; GENETIC DISORDER; GENETIC LINKAGE; GENETICS; PEDIGREE; PHENOTYPE;

CHROMOSOME MAPPING; EPIDEMIOLOGIC METHODS; GENETIC DISEASES, INBORN; HUMANS; LINKAGE (GENETICS); PEDIGREE; PHENOTYPE;

EID: 6944252244     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1433     Document Type: Review

References (100)

1. Anonymous. Breakthrough of the year: The runners-up. Science 302, 2039-2045 (2003).
2. Stefansson, H. et al. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71, 877-892 (2002).
3. Gretarsdottir, S. et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat. Genet. 35, 131-138 (2003).
4. Styrkarsdottir, U. et al. Linkage of osteoporosis to chromosome 20p12 and association to BMP2. PLoS Biol. 1, E69 (2003).
5. Helgadottir, A. et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat. Genet. 36, 233-239 (2004).
6. nd edn. (Oxford University Press, Oxford, 2002).
7. Kraepelin, E. Psychiatrie (JA Barth, Leipzig, 1896; reprinted by Arno, New York, 1976).
8. Kallman, F.J. The Genetics of Schizophrenia (J.J. Augustin, New York, 1938).
9. Kallman, F.J. The genetic theory of schizophrenia: an analysis of 691 schizophrenia twin index families. Am. J. Psychiatry 103, 309-322 (1946).
10. Sullivan, P.F., Kendler, K.S. & Neale, M.C. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 60, 1187-1192 (2003).
11. Gottesman, II & Shields, J. A polygenic theory of schizophrenia. Proc. Natl. Acad. Sci. USA 58, 199-205 (1967).
12. McGue, M., Gottesman, II & Rao, D.C. The transmission of schizophrenia under a multifactorial threshold model. Am. J. Hum. Genet. 35, 1161-1178 (1983).
13. st edn. (eds. King, R.A., Rotter, J.I. & Motulsky, A.G.) 816-836 (Oxford University Press, Oxford, 1992).
14. Risch, N. Linkage strategies for genetically complex traits. I. Multilocus models. Am. J. Hum. Genet. 46, 222-228 (1990).
15. Risch, N. Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am. J. Hum. Genet. 46, 229-241 (1990).
16. Botstein, D., White R.L., Skolnick M., & Davis R.W. Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am. J. Hum. Genet. 32, 314-331 (1980).
17. Gusella, J.F. et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 306, 234-238 (1983).
18. Rommens, J.M. et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245, 1059-1065 (1989).
19. Riordan, J.R. et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245, 1066-1073 (1989).
20. Kerem, B. et al. Identification of the cystic fibrosis gene: genetic analysis. Science 245, 1073-1080 (1989).
21. Hastbacka, J. et at. Linkage disequilibrium mapping in isolated founder populations: diastrophic dysplasia in Finland. Nat. Genet. 2, 204-211 (1992).
22. Baron, M. et al. Genetic linkage between X-chromosome markers and bipolar affective illness. Nature 326, 289-292 (1987).
23. Egeland, J.A. et al. Bipolar affective disorders linked to DNA markers on chromosome 11. Nature 325, 783-787 (1987).
24. St George-Hyslop, P.H. et al. The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 235, 885-890 (1987).
25. Kelsoe, J.R. et al. Re-evaluation of the linkage relationship between chromosome 11p loci and the gene for bipolar affective disorder in the Old Order Amish. Nature 342, 238-243 (1989).
26. Baron, M. et al. Diminished support for linkage between manic depressive illness and X-chromosome markers in three Israeli pedigrees. Nat. Genet. 3, 49-55 (1993).
27. Risch, N. & Merikangas, K. The future of genetic studies of complex human diseases. Science 273, 1516-1517 (1996).
28. Sobel, E. & Lange, K. Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics. Am. J. Hum. Genet. 58, 1323-1337 (1996).
29. Thompson, E. Statistical Inference from Genetic Data on Pedigrees (IMS, Beachwood, Ohio, 2000).
30. Gudmundsson, G. et al. Localization of a gene for peripheral arterial occlusive disease to chromosome 1p31. Am. J. Hum. Genet. 70, 586-592 (2002).
31. Gretarsdottir, S. et al. Localization of a susceptibility gene for common forms of stroke to 5q12. Am. J. Hum. Genet. 70, 593-603 (2002).
32. Kristjansson, K. et al. Linkage of essential hypertension to chromosome 18q. Hypertension 39, 1044-1049 (2002).
33. Hakonarson, H. et al. A major susceptibility gene for asthma maps to chromosome 14q24. Am. J. Hum. Genet. 71, 483-491 (2002).
34. Karason, A. et al. A susceptibility gene for psoriatic arthritis maps to chromosome 16q: evidence for imprinting. Am. J. Hum. Genet. 72, 125-131 (2003).
35. Thorgeirsson, T.E. et al. Anxiety with panic disorder linked to chromosome 9q in Iceland. Am. J. Hum. Genet. 72, 1221-1230 (2003).
36. Stefansson, S.E. et al. Genomewide scan for hand osteoarthritis: a novel mutation in matrilin-3. Am. J. Hum. Genet. 72, 1448-1459 (2003).
37. Reynisdottir, I. et al. Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2. Am. J. Hum. Genet. 73, 323-335 (2003).
38. Bjornsson, A. et al. Localization of a gene for migraine without aura to chromosome 4q21. Am. J. Hum. Genet. 73, 986-993 (2003).
39. Morton, N.E. Sequential tests for the detection of linkage. Am. J. Hum. Genet. 7, 277-318 (1955).
40. rd edn. (Johns Hopkins University Press, Baltimore, 1999).
41. Renwick, J.H. The mapping of human chromosomes. Annu. Rev. Genet. 5, 81-120 (1971).
42. Elston, R.C. The prior probability of autosomal linkage. Ann. Hum. Genet. 38, 341-350 (1975).
43. Feingold, E., Brown, P.O. & Siegmund, D. Gaussian models for genetic linkage analysis using complete high-resolution maps of identity by descent. Am. J. Hum. Genet. 53, 234-251 (1993).
44. Dupuis, J., Brown, P.O. & Siegmund, D. Statistical methods for linkage analysis of complex traits from high-resolution maps of identity by descent. Genetics 140, 843-856 (1995).
45. Lander, E. & Kruglyak, L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat. Genet. 11, 241-247 (1995).
46. Becker, K.G., Barnes, K.C., Bright, T.J. & Wang, S.A. The Genetic Association Database. Nat. Genet. 36, 431-432 (2004).
47. Walther, D.J. et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299, 76 (2003).
48. Wacholder, S., Chanock, S., Garcia-Closas, M., El Ghormli, L. & Rothman, N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl. Cancer Inst. 96, 434-442 (2004).
49. Thomas, D.C. & Clayton, D.G. Betting odds and genetic associations. J. Natl. Cancer Inst. 96, 421-423 (2004).
50. The International HapMap Consortium. The International HapMap Project. Nature 426, 789-796 (2003).
51. Maniatis, N. et al. Positional cloning by linkage disequilibrium. Am. J. Hum. Genet. 74, 846-855 (2004).
52. Botstein, D. & Risch, N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat. Genet. 33 Suppl, 228-237 (2003).
53. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Society B 57, 289-300 (1995).
54. Weller, J.I., Song, J.Z., Heyen, D.W., Lewin, H.A. & Ron, M. A new approach to the problem of multiple comparisons in the genetic dissection of complex traits. Genetics 150, 1699-1706 (1998).
55. Storey, J.D. & Tibshirani, R. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. USA 100, 9440-9445 (2003).
56. Sabatti, C., Service, S. & Freimer, N. False discovery rate in linkage and association genome screens for complex disorders. Genetics 164, 829-833 (2003).
57. Rantakallio, P. Groups at risk in low birth weight infants and perinatal mortality. Acta. Paediatr. Scand. 193, 193:1+ (1969).
58. Jarvelin, M.R. et al. Ecological and individual predictors of birthweight in a northern Finland birth cohort 1986. Paediatr. Perinat. Epidemiol. 11, 298-312 (1997).
59. Freimer, N. & Sabatti, C. The human phenome project. Nat. Genet. 34, 15-21 (2003).
60. Glatt, C.E. & Freimer, N.B. Association analysis of candidate genes for neuropsychiatric disease: the perpetual campaign. Trends Genet. 18, 307-312 (2002).
61. Hariri, A.R., et al. Serotonin transporter genetic variation and the response of the human amygdala. Science 297, 400-403 (2002).
62. Caspi, A. et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301, 386-389 (2003).
63. Weeks, D.E., Lehner, T., Squires-Wheeler, E., Kaufmann, C. & Ott, J. Genet. Epidemiol. 7, 237-243 (1990).
64. Funalot, B., Varenne, O. & Mas, J.L. A call for accurate phenotype definition in the study of complex disorders. Nat. Genet. 36, 3 (2004).
65. Gulcher, J.R., Gretarsdottie, S., King, A. &. Stefansson, K. Reply to "A call for accurate phenotype definition in the study of complex disorders." Nat. Genet. 36, 3-4 (2004).
66. Williams, J.T. & Blangero, J. Power of variance component linkage analysis to detect quantitative trait loci. Ann. Hum. Genet. 6, 545-563 (1999).
67. Almasy, L. & Blangero, J. Endophenotypes as quantitative risk factors for psychiatric disease: rationale and study design. Am. J. Med. Genet. 105, 42-44 (2001).
68. Kong, A. et al. A high-resolution recombination map of the human genome. Nat. Genet. 31, 241-247 (2002).
69. Gudbjartsson, D.F., Jonasson, K., Frigge, M.L. & Kong, A. Allegro, a new computer program for multipoint linkage analysis. Nat. Genet. 25, 12-13 (2000).
70. Hovatta, I. et al. A genomewide screen for schizophrenia genes in an isolated Finnish subpopulation, suggesting multiple susceptibility loci. Am. J. Hum. Genet. 65, 1114-1124 (1999).
71. Ober, C., Tsalenko, A., Parry, R. & Cox, N.J. A second-generation genomewide screen for asthma-susceptibility alleles in a founder population. Am. J. Hum. Genet. 67, 1154-1162 (2000).
72. Garner, C. et al. Linkage analysis of a complex pedigree with severe bipolar disorder, using a Markov chain Monte Carlo method. Am. J. Hum. Genet. 68, 1061-1064 (2001).
73. Schoenberg, S.J. et al. Fine mapping of a multiple sclerosis locus to 2.5 Mb on chromosome 17q22-q24. Hum. Mol. Genet. 11, 2257-2267 (2002).
74. Abkevich, V. et al. Predisposition locus for major depression at chromosome 12q22-12q23.2. Am. J. Hum. Genet. 73, 1271-1281 (2003).
75. Abecasis, G.R. et al. Genomewide scan in families with schizophrenia from the founder population of Afrikaners reveals evidence for linkage and uniparental disomy on chromosome 1. Am. J. Hum. Genet. 74, 403-417 (2004).
76. Carvajal-Carmona, L.G. et al. Genetic demography of Antioquia (Colombia) and the Central Valley of Costa Rica. Hum. Genet. 112, 534-541 (2003).
77. de la Chapelle, A. & Peltomaki, P. The genetics of hereditary common cancers. Curr. Opin. Genet. Dev. 8, 298-303 (1998).
78. Nussbaum, R.L. & Ellis, C.E. Alzheimer's disease and Parkinson's disease N. Engl. J. Med. 348, 1356-1364 (2003).
79. Hennah, W. et al. Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Hum. Mol. Genet. 12, 3151-3159 (2003).
80. Kruglyak, L. & Lander, E.S. Complete multipoint sib-pair analysis of qualitative and quantitative traits. Am. J. Hum. Genet. 57, 439-454 (1995).
81. Kruglyak, L., Daly, M.J., Reeve-Daly, M.P. & Lander, E.S. Parametric and non-parametric linkage analysis: a unified multipoint approach. Am. J. Hum. Genet. 58, 1347-1363 (1996).
82. Hugot, J.P. et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 379, 821-823 (1996).
83. Satsangi, J. et al. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat. Genet. 14, 199-202 (1996).
84. Cho, J.H. et al. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc. Natl. Acad. Sci. USA 95, 7502-7507 (1998).
85. Cavanaugh, J. et al. International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn disease and chromosome 16. Am. J. Hum. Genet. 68, 1165-1171 (2001).
86. Hugot, J.P. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603 (2001).
87. Jawaheer, D. et al. Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families. Arthritis Rheum. 48, 906-916 (2003).
88. MacKay, K. et al. Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sib pairs in the United Kingdom. Arthritis Rheum. 46, 632-639 (2002).
89. Peltonen, L. GenomEUtwin: a strategy to identify genetic influences on health and disease. Twin Res. 6, 354-60 (2003).
90. Ophoff, R.A. et al. Genomewide linkage disequilibrium mapping of severe bipolar disorder in a population isolate. Am. J. Hum. Genet. 71, 565-574 (2002).
91. Vaessen, N. et al. A genome-wide search for linkage-disequilibrium with type 1 diabetes in a recent genetically isolated population from the Netherlands. Diabetes 51, 856-859 (2002).
92. Terwilliger, J.D., Haghighi, F., Hiekkalinna, T.S. & Goring H.H. A bias-ed assessment of the use of SNPs in human complex traits. Curr. Opin. Genet. Dev. 12, 726-734 (2002).
93. Laitinen, T. et al. Characterization of a common susceptibility locus for asthma-related traits. Science 304, 300-304 (2004).
94. Strittmatter, W.J. & Roses, A.D. Apolipoprotein E and Alzheimer's disease. Annu. Rev. Neurosci. 19, 53-77 (1996).
95. Meyer, M.R., et al. APOE genotype predicts when-not whether-one is predisposed to develop Alzheimer disease. Nat. Genet. 19, 321-322 (1998).
96. Bretsky, P. et al. The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging. Neurology 60, 1077-1081 (2003).
97. Bookheimer, S.Y. et al. Patterns of brain activation in people at risk for Alzheimer's disease. N. Engl. J. Med. 343, 450-456 (2000).
98. Small, G.W. et al. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc. Natl. Acad. Sci. USA 97, 6037-6042 (2000).
99. Jordan, B.D. et al. Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing. JAMA 278, 136-140 (1997).
100. Friedman, G. et al. Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurology 52, 244-248 (1999).